- Posuzování léčebné odpovědi u zhoubných nádorů a potřeba úpravy kriterií pro hodnocení účinnosti imunoterapie2010 | 1. lékařská fakulta
- Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profiles2023 | 1. lékařská fakulta
- 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects +11. lékařská fakulta
- Comparison of interim PET response to second-line vs. to first-line treatment in classical Hodgkin lymphoma - contribution to the development of response criteria for relapsed or progressive disease2021 | 2. lékařská fakulta
- Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles2023 | 1. lékařská fakulta
- Translation in solid cancer: are size-based response criteria an anachronism?2015 | Přírodovědecká fakulta
- Změny v diagnostických kritériích a kritériích léčebné odpovědi u mnohočetného myelomu +32008 | Lékařská fakulta v Hradci Králové
- Změny v diagnostických kritériích a kritériích léčebné odpovědi u mnohočetného myelomu +12008 | 1. lékařská fakulta
- Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria2012 | 2. lékařská fakulta
- International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)2017 | 1. lékařská fakulta
- F-18-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?2018 | 2. lékařská fakulta
- Souhrnné srovnání kritérií RECIST 1.1 a iRECIST pro hodnocení odpovědi na onkologickou léčbu solidních tumoru2017 | 3. lékařská fakulta, 1. lékařská fakulta
- Prediction of outcome using positron emission tomography (PET) compared to standard response criteria and potential role in treatment decisions in diffuse large B-cell lymphoma (DLBCL) patientsPublikace bez příslušnosti k fakultě
- Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network2014 | 1. lékařská fakulta
- Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis2011 | 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
- The analysis of factors affecting the threshold on repeated F-18-FDG-PET/CT investigations measured by the PERCIST protocol in patients with esophageal carcinoma2012 | Publikace bez příslušnosti k fakultě
- The analysis of factors affecting the threshold on repeated F-18-FDG-PET/CT investigations measured by the PERCIST protocol in patients with esophageal carcinoma2012 | 1. lékařská fakulta
- Efficacy and Safety of Anti-Interleukin-20 Monoclonal Antibody in Patients With Rheumatoid Arthritis A Randomized Phase IIa Trial2015 | 1. lékařská fakulta
- Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels2013 | Ústřední knihovna, Lékařská fakulta v Plzni
- Repetitivní transkraniální magnetická stimulace (rTMS) v léčbě farmakorezistentní deprese Kazuistická série2003 | 1. lékařská fakulta
- Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia2015 | 2. lékařská fakulta
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis2018 | 1. lékařská fakulta
- Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?2008 | 2. lékařská fakulta
- [F-18] Fluorodeoxyglucose PET/CT and prediction of histopathological response to neoadjuvant chemotherapy for adenocarcinoma of the oesophagus and oesophagogastric junction2018 | 1. lékařská fakulta, 2. lékařská fakulta
- Favorable outcome in infants with AML after intensive first- nd second-line treatment: an AML-BFM study group report2012 | 2. lékařská fakulta